Altria Bets on Pricing: A Cushion Against Falling Volumes?

22.08.25 17:08 Uhr

Werte in diesem Artikel
Aktien

56,00 EUR 0,32 EUR 0,57%

Indizes

PKT PKT

17.907,2 PKT -58,0 PKT -0,32%

3.298,5 PKT -13,1 PKT -0,39%

6.604,7 PKT -33,3 PKT -0,50%

Altria Group, Inc. (MO) is currently leaning on its pricing strategy to counter the ongoing decline in cigarette volumes, a persistent challenge in the tobacco industry. The company's second quarter of 2025 results show a significant 10.2% drop in domestic cigarette shipment volume for its smokeable products segment, indicating both the broader industry decline and rising competition from flavored disposable e-vapor products. For the first half, domestic cigarette shipment volume declined 11.9%.Yet, despite these substantial volume headwinds, the smokeable products segment’s adjusted operating companies income (“OCI”) improved 4.2% for the second quarter and 3.5% for the first half. This seemingly contradictory performance is explained by Altria's strong net price realization, which was an impressive 10% for the quarter and 10.4% for the first half. This ability to consistently raise prices effectively in a declining market indicates a significant degree of brand loyalty among existing consumers and a strategic focus on maximizing revenues from each unit sold. Altria's use of this pricing power appears to be a direct response to the shrinking demand, helping it address financial health and profitability in a challenging industry. This approach can offer a notable means for the company to support its core business as market dynamics continue to evolve.Altria's Peer CheckPhilip Morris International Inc. (PM) continues to demonstrate that pricing power remains a central engine of its profitability. In the second quarter of 2025, Philip Morris delivered organic net revenue growth of 6.8% (more than 8% excluding the Indonesia technical impact) and organic adjusted operating income growth of 14.9%. Notably, Philip Morris’ performance was driven by higher combustible pricing and modest smoke-free gains.Meanwhile, Turning Point Brands, Inc. (TPB) is strategically shifting its focus toward high-growth product categories. In the second quarter of 2025, Turning Point Brands' Modern Oral nicotine pouch revenues increased nearly eightfold year over year. The company is making significant investments in sales and marketing to expand distribution for its FRE and ALP brands. Turning Point Brands is also investing in its sales force to support expansion plans.MO’s Price Performance, Valuation & EstimatesShares of Altria have gained 13.3% in the past month compared with the industry’s growth of 8.6%.Image Source: Zacks Investment ResearchFrom a valuation standpoint, MO trades at a forward price-to-earnings ratio of 12.33X, down from the industry’s average of 15.78X.Image Source: Zacks Investment ResearchThe Zacks Consensus Estimate for MO’s 2025 and 2026 earnings per share has inched up by 2 cents each in the past 30 days to $5.39 and $5.55, respectively.Image Source: Zacks Investment ResearchAltria currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.One Big Gain, Every Trading DayTo help you take full advantage of this market, you’re invited to access every stock recommendation in all our private portfolios - for just $1.Zacks private portfolio services that closed 256 double and triple-digit winners in 2024 alone. That’s about one big gain every day the market was open. Of course, not all our picks are winners, but members have seen recent gains as high as +627% +1,340%, and +1,708%.Imagine how much you could profit with a steady stream of real-time picks from all our services that cover a number of strategies to suit a variety of investing and trading styles.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Altria Group, Inc. (MO): Free Stock Analysis Report Philip Morris International Inc. (PM): Free Stock Analysis Report Turning Point Brands, Inc. (TPB): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Altria und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Altria

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Altria

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Altria Inc.

Wer­bung

Analysen zu Altria Inc.

DatumRatingAnalyst
02.04.2020Altria HoldJefferies & Company Inc.
12.07.2019Altria buyGoldman Sachs Group Inc.
31.07.2017Altria NeutralUBS AG
31.07.2017Altria BuyStifel, Nicolaus & Co., Inc.
31.07.2017Altria Sector PerformRBC Capital Markets
DatumRatingAnalyst
12.07.2019Altria buyGoldman Sachs Group Inc.
31.07.2017Altria BuyStifel, Nicolaus & Co., Inc.
27.06.2016Altria Group BuyStifel, Nicolaus & Co., Inc.
02.02.2015Altria Group BuyStifel, Nicolaus & Co., Inc.
31.10.2014Altria Group BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
02.04.2020Altria HoldJefferies & Company Inc.
31.07.2017Altria NeutralUBS AG
31.07.2017Altria Sector PerformRBC Capital Markets
09.08.2012Altria Group neutralCitigroup Corp.
26.07.2012Altria Group neutralUBS AG
DatumRatingAnalyst
23.03.2017Altria Group UnderperformRBC Capital Markets
27.04.2005Update UST Inc.: UnderperformGoldman Sachs
27.04.2005UST: UnderweightJP Morgan
24.01.2005UST: UnderweightJP Morgan

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Altria Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen